In vivo RNAi screen identifies NLK as a negative regulator of mesenchymal activity in glioblastoma.
Sa JK, Yoon Y, Kim M, Kim Y, Cho HJ, Lee JK, Kim GS, Han S, Kim WJ, Shin YJ, Joo KM, Paddison PJ, Ishitani T, Lee J, Nam DH.
Sa JK, et al. Among authors: ishitani t.
Oncotarget. 2015 Aug 21;6(24):20145-59. doi: 10.18632/oncotarget.3980.
Oncotarget. 2015.
PMID: 26023737
Free PMC article.